New modulated design, docking and synthesis of carbohydrate-conjugate heterobimetallic CuII-SnIV complex as potential topoisomerase II inhibitor: In vitro DNA binding, cleavage and cytotoxicity against human cancer cell lines

New metal-based cancer chemotherapeutic glycoconjugate heterobimetallic complexes were designed and synthesized as multifaceted DNA binding agent to act as a potential antitumor agent.